Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 3D Systems (DDD) downgraded to Underweight from Neutral and Stratasys (SSYS) downgraded to Neutral from Overweight at Piper Jaffray with analyst Troy Jensen saying his channel checks and quarterly 3D printing survey indicated the industry experienced a "significant slowdown in system demand" in the June quarter. 2. Infosys (INFY) downgraded to Neutral from Outperform at Credit Suisse and to Neutral from Buy at Nomura. Credit Suisse analyst Anantha Narayan downgraded Infosys citing a lack of near-term catalysts for shares to move higher amid the company's slowing growth. 3. KB Home (KBH) downgraded to Neutral from Buy at Buckingham with the firm citing moderating 2017 earnings growth, leverage and inconsistent execution, and recent share strength. 4. CONSOL (CNX) and Devon Energy (DVN) downgraded to Accumulate from Buy at KLR Group with analyst John Gerdes citing valuation. 5. Merck (MRK) downgraded to Market Perform from Outperform at BMO Capital with the firm citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here

Check out this morning's top movers from around Wall Street, compiled by The Fly.  UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here

FY24 consensus $8.56. Raises FY24 revenue view to $63.1B-$64.3B from $62.7B-$64.2B, consensus $63.83B.

Reports Q1 revenue $15.8B, consensus $15.2B. "Merck has begun 2024 with continuing momentum in our business. We are harnessing the power of innovation to advance our deep pipeline and are maximizing the impact of our broad commercial portfolio for the benefit of patients," said Robert Davis, chairman and chief executive officer, Merck. "We drove strong growth across key therapeutic areas, executed strategic business development, and in the U.S., we are now launching WINREVAIR, a significant new product in the cardiometabolic space for adults with pulmonary arterial hypertension, a progressive and debilitating disease. We have important opportunities ahead of us across all areas of our business, and we are highly focused on realizing them."

Notable companies reporting before tomorrow's open, with earnings consensus, include Merck (MRK), consensus $1.87... Caterpillar (CAT), consensus $5.14... Comcast (CMSCA), consensus 99c... Honeywell (HON), consensus $2.17... Bristol-Myers (BMY), consensus ($4.44)... Altria (MO), consensus $1.15... Keurig Dr. Pepper (KDP), consensus 35c... GE Vernova (GEV), consensus (37c)... Royal Caribbean (RCL), consensus $1.33... Tractor Supply (TSCO), consensus $1.72... Mobileye (MBLY), consensus (6c)... Textron (TXT), consensus $1.23... LabCorp (LH), consensus $3.48... Southwest Airlines (LUV), consensus (34c)... American Airlines (AAL), consensus (29c)... Harley-Davidson (HOG), consensus $1.51.